In this context, it is shown that IL-17 is an important driver of destructive inflammation in T1D pathogenesis [13,14] in animal models, suggesting it may have a potential role in the initiation and progression of impairments in insulin secretion in humans pre-T1D. Here, INS is linked to type 1 diabetes mellitus.